Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pacira Pharmaceuticals
Biotech
Kineta sells Genentech, Merck deals to investor ahead of merger
Tidying up the portfolio ahead of its merger with TuHURA, Kineta is selling the deals to an investment firm and offloading a pain prospect to Pacira.
Nick Paul Taylor
Feb 10, 2025 7:45am
Pacira to absorb pain-relief devicemaker Myoscience for $220M
Mar 5, 2019 12:22pm
Pacira pours up to $25M into TELA Bio
Oct 27, 2017 9:30am
